Finance

Lists
Why is SYNACT down 14.77%?
Dive Deeper
SYNACT:STO
SynAct Pharma AB
SEK 13.62
-14.77%
(-2.36) 1D
Nov 13, 4:56:08 PM GMT+1  ·   SEK
All symbols
SymbolPriceChange% Change
Generating top insights for SYNACT...
Open
SEK 15.38
High
SEK 15.48
Low
SEK 12.98
Mkt. cap
765.63M
Avg. vol.
89.37K
Volume
457.60K
52-wk high
SEK 24.50
52-wk low
SEK 7.05
EPS
-SEK 1.87
Shares outstanding
56.21M
No. of employees
8
Open
SEK 15.38
High
SEK 15.48
Low
SEK 12.98
Mkt. cap
765.63M
Avg. vol.
89.37K
Volume
457.60K
52-wk high
SEK 24.50
52-wk low
SEK 7.05
EPS
-SEK 1.87
Shares outstanding
56.21M
No. of employees
8
News stories
From web sources and news partners
About SynAct Pharma AB
CEOJeppe Øvlesen
Employees8
FoundedMar 14, 2012
Headquarters-
SectorHealth Care
IndustryBiotechnology
Previous reportsAll values in SEK
Loading Previous Earnings...
Revenue
Net income
All values in SEK
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
12.32M
22.87M
15.46M
22.20M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
10.45M
7.71M
9.16M
7.81M
Operating expense
22.47M
30.56M
24.56M
30.09M
Total operating expenses
22.47M
30.56M
24.56M
30.09M
Operating income
-22.47M
-30.56M
-24.56M
-30.09M
Other non operating income
-
1.00K
-1.00K
-
EBT including unusual items
-22.90M
-30.54M
-24.91M
-32.26M
EBT excluding unusual items
-22.90M
-30.54M
-24.91M
-32.26M
Income tax expense
27.00K
-5.06M
-2.88M
-80.00K
Effective tax rate
-0.12%
16.56%
11.55%
0.25%
Other operating expenses
-298.00K
-23.00K
-68.00K
77.00K
Net income
-22.93M
-25.49M
-22.03M
-32.18M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
2.13M
13.00K
-
-
Interest expense
-
-
-353.00K
-2.17M
Net interest expenses
2.13M
13.00K
-353.00K
-2.17M
Depreciation and amortization charges
-
-
-
-
EBITDA
-22.47M
-30.55M
-24.55M
-30.08M
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google apps